Moreover, in a recent study, we report that increased 5-HT1A receptor availability in the dorsolateral prefrontal cortex, induced by transcranial magnetic stimulation (TMS), may lead to a decrease in depression severity in patients with TRD [14]. The gene discussed is HTR1A; the disease is depressive symptom measurement.